Can preoperative diffusion-weighted MRI predict postoperative hepatic insufficiency after curative resection of HBV-related hepatocellular carcinoma? A pilot study

Magnetic Resonance Imaging

Volumn 28, Issue 6, 2010, Pages 802-811

  Kim, Seung Up ^a,b   Kim, Young Chul ^a   Choi, Ji Soo ^a   Kim, Kyung Sik ^a,b   Choi, Gi Hong ^a,b   Choi, Jin Sub ^a,b   Park, Jun Yong ^a,b   Kim, Do Young ^a,b   Ahn, Sang Hoon ^a,b   Choi, Eun Hee ^a   Park, Young Nyun ^a,b   Chon, Chae Yoon ^a,b   Han, Kwang Hyub ^a,b   Kim, Myeong Jin ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Liver Cirrhosis Clinical Research Center   (South Korea)

Author keywords

Apparent diffusion coefficient; Chronic hepatitis B; Cirrhosis; Diffusion weighted magnetic resonance imaging; Fibrosis; Hepatectomy; Hepatitis B virus; Hepatocellular carcinoma; Liver stiffness measurement; Transient elastography

Indexed keywords

ADULT; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; HEPATITIS B; HUMAN; HYPERBILIRUBINEMIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FIBROSIS; MALE; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RELIABILITY; AGED; AREA UNDER THE CURVE; CARCINOMA, HEPATOCELLULAR; COMPLICATION; EVALUATION STUDY; HEPATIC INSUFFICIENCY; LIVER; LIVER NEOPLASMS; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY; PILOT STUDY; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE; PREOPERATIVE CARE; PROCEDURES; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SURVIVAL; VIROLOGY;

ADULT; AGED; AREA UNDER CURVE; CARCINOMA, HEPATOCELLULAR; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HEPATIC INSUFFICIENCY; HEPATITIS B; HUMANS; HYPERBILIRUBINEMIA; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; OBSERVER VARIATION; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SURVIVAL ANALYSIS;

HEPATITIS B VIRUS;

EID: 77953807666     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2010.03.018     Document Type: Article

References (43)

1. Lee J.G., Kang C.M., Park J.S., Kim K.S., Yoon D.S., Choi J.S., et al. The actual five-year survival rate of hepatocellular carcinoma patients after curative resection. Yonsei Med J 2006, 47:140-143.
2. Lai E.C., Fan S.T., Lo C.M., Chu K.M., Liu C.L., Wong J. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg 1995, 221:291-298.
3. Shuto T., Hirohashi K., Kubo S., Tanaka H., Tsukamoto T., Yamamoto T., et al. Changes and results of surgical strategies for hepatocellular carcinoma: results of a 15-year study on 452 consecutive patients. Surg Today 1998, 28:1124-1129.
4. Torzilli G., Makuuchi M., Inoue K., Takayama T., Sakamoto Y., Sugawara Y., et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 1999, 134:984-992.
5. Fan S.T., Ng I.O., Poon R.T., Lo C.M., Liu C.L., Wong J. Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival. Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival. Arch Surg 1999, 134:1124-1130.
6. Furuhama K., Yabe K. Application of hepatic tolerance tests to the functional reserve assessment in rat models of fatty liver. J Vet Med Sci 1998, 60:635-637.
7. Asano M., Ozawa K., Tobe T. Postoperative prognosis as related to blood ketone body ratios in hepatectomized patients. Eur Surg Res 1983, 15:302-311.
8. Noguchi T., Imai T., Mizumoto R. Preoperative estimation of surgical risk of hepatectomy in cirrhotic patients. Hepatogastroenterology 1990, 37:165-171.
9. Mullen J.T., Ribero D., Reddy S.K., Donadon M., Zorzi D., Gautam S., et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 2007, 204:854-862.
10. Schneider P.D. Preoperative assessment of liver function. Surg Clin North Am 2004, 84:355-373.
11. Kim S.U., Ahn S.H., Park J.Y., Kim D.Y., Chon C.Y., Choi J.S., et al. Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan®) before curative resection of hepatocellular carcinoma: a pilot study. Hepatol Int 2008, 2:471-477.
12. Catalano O.A., Singh A.H., Uppot R.N., Hahn P.F., Ferrone C.R., Sahani D.V. Vascular and biliary variants in the liver: implications for liver surgery. Radiographics 2008, 28:1263-1287.
13. Sahani D., Mehta A., Blake M., Prasad S., Harris G., Saini S. Preoperative hepatic vascular evaluation with CT and MR angiography: implications for surgery. Radiographics 2004, 24:1367-1380.
14. Lewin M., Poujol-Robert A., Boëlle P.Y., Wendum D., Lasnier E., Viallon M., et al. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 2007, 46:658-665.
15. Koinuma M., Ohashi I., Hanafusa K., Shibuya H. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging 2005, 22:80-85.
16. Boulanger Y., Amara M., Lepanto L., Beaudoin G., Nguyen B.N., Allaire G., et al. Diffusion-weighted MR imaging of the liver of hepatitis C patients. NMR Biomed 2003, 16:132-136.
17. Torzilli G., Minagawa M., Takayama T., Inoue K, Hui A.M., Kubota K., et al. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 1999, 30:889-893.
18. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
19. Nanashima A., Yamaguchi H., Tanaka K., Shibasaki S., Tsuji T., Ide N., et al. Preoperative serum hyaluronic acid level as a good predictor of posthepatectomy complications. Surg Today 2004, 34:913-919.
20. Ohwada S., Kawate S., Hamada K., Yamada T., Sunose Y., Tsutsumi H., et al. Perioperative real-time monitoring of indocyanine green clearance by pulse spectrophotometry predicts remnant liver functional reserve in resection of hepatocellular carcinoma. Br J Surg 2006, 93:339-346.
21. Kim D.Y., Kim S.U., Ahn S.H., Park J.Y., Lee J.M., Park Y.N., et al. Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B. Dig Dis Sci 2009, 54:1758-1763.
22. Kim S.U., Ahn S.H., Park J.Y., Kang W., Kim D.Y., Park Y.N., et al. Liver stiffness measurement in combination with non-invasive markers for the improved diagnosis of B-viral liver cirrhosis. J Clin Gastroenterol 2009, 43:267-271.
23. Poynard T., Bedossa P. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups. J Viral Hepat 1997, 4:199-208.
24. Wai C.T., Greenson J.K., Fontana R.J., Kalbfleisch J.D., Marrero J.A., Conjeevaram H.S., et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003, 38:518-526.
25. Kim B.K., Kim S.A., Park Y.N., Cheong J.Y., Kim H.S., Park J.Y., et al. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver int 2007, 27:969-976.
26. Dittrich M., Milde S., Dinkel E., Baumann W., Weitzel D. Sonographic biometry of liver and spleen size in childhood. Pediatr Radiol 1983, 13:206-211.
27. Makuuchi M., Kosuge T., Takayama T., Yamazaki S., Kakazu T., Miyagawa S., et al. Surgery for small liver cancers. Semin Surg Oncol 1993, 9:298-304.
28. Choi J.Y., Kim M.J., Chung Y.E., Kim J.Y., Jones A.C., de Becker J., et al. Abdominal applications of 3.0-T MR imaging: comparative review versus a 1.5-T system. Radiographics 2008, 28:e30.
29. Akisik F.M., Sandrasegaran K., Aisen A.M., Lin C., Lall C. Abdominal MR imaging at 3.0 T. Radiographics 2007, 27:1433-1444. [discussion 1462-4].
30. Marcellin P., Ziol M., Bedossa P., Douvin C., Poupon R., de Lédinghen V., et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009, 29:242-247.
31. Friedrich-Rust M., Ong M.F., Martens S., Sarrazin C., Bojunga J., Zeuzem S., et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008, 134:960-974.
32. Taouli B., Vilgrain V., Dumont E., Daire J.L., Fan B., Menu Y. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 2003, 226:71-77.
33. Aubé C., Racineux P.X., Lebigot J., Oberti F., Croquet V., Argaud C., et al. Diagnosis and quantification of hepatic fibrosis with diffusion weighted MR imaging: preliminary results. J Radiol 2004, 85:301-306.
34. Castera L., Forns X., Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008, 48:835-847.
35. Ogawa E., Furusyo N., Toyoda K., Takeoka H., Otaguro S., Hamada M., et al. Transient elastography for patients with chronic hepatitis B and C virus infection: Non-invasive, quantitative assessment of liver fibrosis. Hepatol Res 2007, 37:1002-1010.
36. Cho S.G., Kim M.Y., Kim H.J., Kim Y.S., Choi W., Shin S.H., et al. Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. Radiology 2001, 221:740-746.
37. Materne R., Smith A.M., Peeters F., Dehoux J.P., Keyeux A., Horsmans Y., et al. Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med 2002, 47:135-142.
38. Annet L., Materne R., Danse E., Jamart J., Horsmans Y., Van Beers B.E. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 2003, 229:409-414.
39. Aguirre D.A., Behling C.A., Alpert E., Hassanein T.I., Sirlin C.B. Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology 2006, 239:425-437.
40. Lucidarme O., Baleston F., Cadi M., Bellin M.F., Charlotte F., Ratziu V., et al. Non-invasive detection of liver fibrosis: is superparamagnetic iron oxide particle-enhanced MR imaging a contributive technique?. Eur Radiol 2003, 13:467-474.
41. Huwart L., Salameh N., ter Beek L., Vicaut E., Peeters F., Sinkus R., et al. MR elastography of liver fibrosis: preliminary results comparing spin-echo and echo-planar imaging. Eur Radiol 2008, 18:2535-2541.
42. Rouvière O., Yin M., Dresner M.A., Rossman P.J., Burgart L.J., Fidler J.L., et al. MR elastography of the liver: preliminary results. Radiology 2006, 240:440-448.
43. Poynard T., Halfon P., Castera L., Munteanu M., Imbert-Bismut F., Ratziu V., et al. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem 2007, 53:1615-1622. FibroPaca Group.